Leading the Future of Microsurgery: Medical Microinstruments is Empowering Surgeons and Redefining Healthcare Standards with Symani® System

Medical Microinstruments (MMI) is at the forefront of revolutionizing microsurgery with its innovative robotic solutions. As an innovator in the field, MMI has developed the first teleoperated robotic platform for suturing in open surgery, equipped with wristed microinstruments. This groundbreaking technology offers surgeons motion scaling and tremor elimination, enhancing precision and control during procedures.

With a vision to advance surgical capabilities, MMI aims to not only improve existing procedures but also enable new ones across various domains of microsurgery. From post-oncological and trauma reconstructions to ophthalmology, organ transplantation, and pediatric surgery, the Symani System opens doors to a multitude of possibilities.

Driven by a mission to expand access to advanced surgical techniques, MMI strives to empower surgeons worldwide while simultaneously reducing costs for patients, hospitals, and society as a whole. With FDA authorization in the U.S. and CE Mark certification in Europe, MMI's Symani System is poised to transform the landscape of microsurgery globally.

The Symani® Surgical System

Symani® Surgical System, a revolutionary advancement in microsurgery designed to elevate patient outcomes and surgical precision. With its cutting-edge technology, Symani is transforming the landscape of microsurgery for patients, surgeons, and hospitals alike.

Revolutionizing Microsurgery

The Symani Surgical System represents a breakthrough in surgical innovation, featuring the world’s smallest robotic instruments meticulously engineered to navigate even the tiniest vessels with unparalleled precision. These instruments, ranging from 8-0 to 12-0 sutures, empower surgeons to perform intricate procedures with enhanced control and accuracy.

Unrivaled Precision and Control

Equipped with seven degrees of freedom for unparalleled wrist flexibility and versatility, the Symani System offers motion scaling capabilities of 7-20x while preserving natural dexterity. With over 500 successful cases performed worldwide and growing, Symani is redefining the standards of microsurgical excellence.

State-of-the-Art Technology

The Symani Surgical System comprises a portable cart housing a macropositioner and micromanipulators, facilitating seamless instrument movement and positioning. The ergonomically designed Surgeon Console ensures surgeon comfort during lengthy procedures, with OperaAir® controllers and footswitches providing complete control over instrumentation.

NanoWrist® Instruments

At the heart of Symani's precision lies its NanoWrist instruments, featuring the world’s smallest robotic wrist for delicate anatomical manipulation. From multi-functional needle holders to dilators, this proprietary portfolio enables surgeons to navigate micro and supermicro vessels with unparalleled accuracy.

Enhancing Surgical Capabilities

Symani is revolutionizing microsurgery by offering unparalleled precision, tremor reduction, and motion scaling capabilities. Designed to perform microsurgical anastomosis, suturing, and ligation on blood vessels, lymphatic ducts, and nerves, Symani is revolutionizing a broad spectrum of surgical procedures including reconstructive free flap surgery and replantation.

Unlocking New Possibilities

With its powerful combination of miniaturized instruments and state-of-the-art technology, Symani is poised to unlock new possibilities in microsurgery. From reducing errors and vessel trauma during suturing to translating natural surgeon movements into precise micro-instrument actions, Symani is paving the way for enhanced surgical outcomes and patient care.

Clinical Applications of the Symani® Surgical System

Microvascular Vessel Repair

In reconstructive free flap surgeries and replantation procedures, repairing tiny blood vessels is crucial for restoring blood flow. Symani empowers microsurgeons to delicately connect these small arteries and veins with precision and control. By enabling surgeons to perform complex procedures like perforator flaps more effectively, Symani opens up new possibilities for less invasive treatment options and better outcomes for patients.

Lymphatic Repair

Individuals suffering from lymphedema often seek surgical interventions to alleviate symptoms and improve their quality of life. Procedures like lymphovenous anastomosis or bypass (LVA/LVB) and vascularized lymph node transfer (VLNT) can help reduce swelling and promote fluid drainage. Symani assists surgeons in performing these delicate procedures by facilitating the connection of tiny lymphatic ducts to nearby veins or transplanting lymph nodes to affected areas, ultimately enhancing patient comfort and well-being.

Peripheral Nerve Repair

Traumatic injuries to peripheral nerves in the arms and legs can significantly affect a patient's daily life. Restoring sensation to the affected area through reconstructive surgery is essential, requiring precise repair of the small nerves. Symani supports surgeons in these intricate procedures by providing enhanced precision, potentially leading to improved outcomes and quicker recovery for patients.

Enhancing Breast Cancer Care with Symani®

Addressing Post-Treatment Challenges

Breast cancer patients encounter numerous challenges post-treatment, from decisions regarding reconstructive surgery following mastectomy to concerns about developing lymphedema. Symani plays a crucial role in supporting a comprehensive approach to cancer care for these patients, ensuring they have access to advanced treatment options.

Access to Advanced Reconstructive Surgery

Symani offers breast cancer patients access to state-of-the-art reconstructive options using their own tissue and robotic technology. Autologous breast reconstruction, facilitated by Symani, boasts advantages over implant-based reconstruction, including lower failure rates and higher patient satisfaction. This innovative approach enhances patient outcomes and reduces the risk of complications.

Precision at the Micro Level

Symani's NanoWrist® instruments, featuring the world’s smallest surgical robotic wrist, enable surgeons to replicate human hand movements at a micro level with remarkable precision. Tremor filtration and motion scaling technology ensure precise needle and suture placement, contributing to increased vessel patency and reduced trauma. By avoiding costly re-interventions, Symani enhances patient care while optimizing healthcare resources.

MMI’s Education and Training Support

Explore the wide array of educational materials aimed at enhancing knowledge of robotic microsurgery. Discover topics such as the robotic DIEP perforator-to-perforator technique and lymphatic micro and supermicrosurgery through insightful discussions and experiences shared by seasoned users worldwide. Additionally, stay updated with the latest literature on robotic microsurgery and uncover potential clinical applications for the Symani system.

Explore a collection of case studies showcasing real-world applications and outcomes of the Symani Surgical System. These studies offer valuable insights into the efficacy and versatility of Symani across various surgical scenarios, providing actionable information for surgeons and care teams.

Embark on your robotic microsurgery journey with Symani through professional education and training programs meticulously designed to support surgeons and care teams. Our phased approach to training ensures comprehensive skill development, with vetted curriculum tailored to each member of your team. Gain access to exclusive resources available only to Symani users and discover opportunities for continued growth and advancement in robotic microsurgery.

Mark Toland, CEO, Medical Microinstruments

Before joining MMI, Mark Toland served as the President and CEO of Corindus where he transformed the company into the industry leader in vascular robotics with the only approved system for coronary, peripheral, and neurovascular indications. The Siemens Healthineers acquisition of Corindus for $1.1 billion was the fifth largest medical technology acquisition of 2019. Prior to Corindus, Mark served as Senior Vice President of Boston Scientific, where he built the company’s global solutions business and led all aspects of the U.S. commercial team’s cardiovascular businesses, which represented approximately $4 billion in revenue. 

Mark brings over 25 years of medical device experience to MMI. In addition, he serves on the Board of Directors for Moon Surgical; Cardiologs, a cardiovascular AI company that was acquired by global health technology leader, Philips, in 2021; and Amplitude Vascular Systems, an intravascular lithotripsy company. He also serves as a Managing Partner at BioStar Capital, a healthcare focused venture capital firm. Mr. Toland holds a BS in Business Administration from the University of Louisville.

Featuring the world’s smallest robotic instruments, meticulously engineered to navigate even the tiniest vessels with precision, Symani® offers surgeons unprecedented levels of control and accuracy.